Earnings Summary

Globus Medical, Inc.’s revenue jumped 124.6% since last year same period to $616.53Mn in the Q4 2023. On a quarterly growth basis, Globus Medical, Inc. has generated 60.71% jump in its revenue since last 3-months.

Globus Medical, Inc.’s net profit fell -69.97% since last year same period to $15.03Mn in the Q4 2023. On a quarterly growth basis, Globus Medical, Inc. has generated 1406.41% jump in its net profits since last 3-months.

Globus Medical, Inc.’s net profit margin fell -86.63% since last year same period to 2.44% in the Q4 2023. On a quarterly growth basis, Globus Medical, Inc. has generated 837.37% jump in its net profit margins since last 3-months.

Globus Medical, Inc.’s price-to-earnings ratio after this Q4 2023 earnings stands at 48.07.

Globus Medical, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.57 - a -6.56% fall from last quarter’s estimates.

Globus Medical, Inc.’s earning per share (EPS) estimates for the current year stand at 0.57.

Globus Medical, Inc.’s earning per share (EPS) jumped 1.69% since last year same period to 0.6 in the Q4 2023. This indicates that the Globus Medical, Inc. has generated 1.69% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Globus Medical, Inc.’s return on assets (ROA) stands at 0.05.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Globus Medical, Inc.’s return on equity (ROE) stands at 0.04.